UNITED THERAPEUTICS CORP
Net SellingUTHR·US·🇺🇸 US
1%buys·99%sells
11,386 transactions$15.1MTotal buys·43 buys
$2.0BTotal sells·5,219 sells
2222 insiders
Last: Apr 2, 2026
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 9, 26 | EDGEMOND JAMES | Exercise | - | |
| Apr 9, 26 | EDGEMOND JAMES | Sell | $94K | |
| Apr 9, 26 | EDGEMOND JAMES | Sell | $1.0M | |
| Apr 9, 26 | EDGEMOND JAMES | Sell | $710K | |
| Apr 9, 26 | EDGEMOND JAMES | Sell | $659K | |
| Apr 9, 26 | EDGEMOND JAMES | Sell | $934K | |
| Apr 9, 26 | EDGEMOND JAMES | Sell | $915K | |
| Apr 9, 26 | EDGEMOND JAMES | Sell | $1.1M | |
| Apr 9, 26 | EDGEMOND JAMES | Sell | $322K | |
| Apr 9, 26 | EDGEMOND JAMES | Exercise | $1.4M |
EDGEMOND JAMES (CFO) recently executed a sell of $94K in UNITED THERAPEUTICS CORP shares on April 9, 2026. Overall insider sentiment is bearish (99% sales).
UNITED THERAPEUTICS CORP (UTHR) has recorded 11 386 insider operations, including 43 open-market purchases ($15.1M), 5 219 sales ($2.0B) and 6 124 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (99% sales).
Insider activity at UNITED THERAPEUTICS CORP is sustained, with operations recorded in 11 of the last 12 months — a sign of regular regulatory filings.
Among the most active insiders are ROTHBLATT MARTINE A (CEO), LILLY ELI & CO (CEO) & Ferrari John Maxim (CFO), with respectively 5625, 55, 301 transactions.
Across all 11 507 recorded transactions, the breakdown by type is: exercise (5342, 46%), sells (5323, 46%), disposition (415, 4%), grant (318, 3%), gift (56, 0%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
UNITED THERAPEUTICS CORP has recorded 11 386 insider operations in total, including 43 open-market purchases ($15.1M), 5 219 sales ($2.0B) and 6 124 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on April 2, 2026.
Insiders at UNITED THERAPEUTICS CORP are currently net sellers, with 1% purchases and 99% sales across all reported transactions. Total buy volume is $15.1M versus $2.0B in sales, indicating a bearish insider sentiment.
InsiderLens tracks 22 insiders at UNITED THERAPEUTICS CORP (UTHR). ROTHBLATT MARTINE A (CEO, 5625 tx), LILLY ELI & CO (CEO, 55 tx), Ferrari John Maxim (CFO, 301 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for UTHR is bearish, based on a 1% buy ratio across 5 262 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for UNITED THERAPEUTICS CORP comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.